Who says Americans can't "do irony"!
John Mack has a great post about AZ trying to replace Vytorin with Crestor!
The irony:
The ENHANCE and METEOR studies are similar in one respect: each studied only a few hundred people over a limited time period. Merck and Schering-Plough are trying to say we shouldn't place too much emphasis on a clinical trial involving only a few hundred people. Yet, a clinical trial involving only a few hundred people was good enough for the FDA to approve a new Crestor indication worth hundred of millions of dollars to AstraZeneca!
Hmm!
Maybe the FDA should rethink that Crestor indication!
No comments:
Post a Comment